A detailed history of Mediolanum International Funds LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Mediolanum International Funds LTD holds 525,076 shares of BSX stock, worth $53.5 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
525,076
Previous 456,972 14.9%
Holding current value
$53.5 Million
Previous $38 Billion 23.53%
% of portfolio
0.61%
Previous 0.53%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

BUY
$83.62 - $91.5 $5.69 Million - $6.23 Million
68,104 Added 14.9%
525,076 $47 Billion
Q3 2024

Oct 23, 2024

SELL
$72.96 - $84.0 $533,921 - $614,712
-7,318 Reduced 1.58%
456,972 $38 Billion
Q2 2024

Aug 13, 2024

SELL
$67.33 - $77.71 $5.85 Million - $6.76 Million
-86,944 Reduced 15.77%
464,290 $33.4 Billion
Q1 2024

May 03, 2024

BUY
$57.6 - $68.62 $31.8 Million - $37.8 Million
551,234 New
551,234 $37.8 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Mediolanum International Funds LTD Portfolio

Follow Mediolanum International Funds LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mediolanum International Funds LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mediolanum International Funds LTD with notifications on news.